Article
Viral soluble decoy receptor as a novel treatment for IFN-I triggered diseases
2025-08-15
Abstract excerpt
Besides its antiviral action, type I interferon (IFN-I) plays a key role in triggering the inflammatory response and immunopathology in a group of autoinflammatory disorders known as interferonopathies. Current therapies for these diseases focus on blocking IFN-I signaling at different levels, but with incomplete success. Throughout evolution, to counteract the host immune response, poxviruses have developed decoy...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 104a927f-200d-5837-9b9b-9b60966e38d2
- DOI
- 10.1101/2025.08.12.669887
